ftc pharmacy benefit managers - Search News

Pharmacy managers inflated drug prices by $7.3 billion

USA Today · 6h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

Hosted on MSN · 35m

Report: 'Pharmacy Benefit Managers' profited billions by raising prices of 'specialty drugs'

The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without substantiating evidence."

US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated pharmacies, the U.S.

1don MSN

PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

1don MSN

FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%

The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results